KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 2 filers reported holding KARUNA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $6,892,322 | +58.6% | 21,776 | -15.3% | 0.04% | +48.0% |
| Q3 2023 | $4,346,628 | -22.0% | 25,706 | -0.0% | 0.02% | -10.7% |
| Q2 2023 | $5,575,647 | +16.4% | 25,712 | -2.5% | 0.03% | +7.7% |
| Q1 2023 | $4,789,484 | -7.5% | 26,368 | +0.0% | 0.03% | -7.1% |
| Q4 2022 | $5,180,526 | -12.6% | 26,364 | +0.0% | 0.03% | -6.7% |
| Q3 2022 | $5,928,000 | +69.3% | 26,356 | -4.8% | 0.03% | +87.5% |
| Q2 2022 | $3,501,000 | +2.7% | 27,674 | +2.9% | 0.02% | +45.5% |
| Q1 2022 | $3,408,000 | -3.8% | 26,883 | -0.6% | 0.01% | +22.2% |
| Q4 2021 | $3,543,000 | +3.4% | 27,043 | -3.5% | 0.01% | +12.5% |
| Q3 2021 | $3,428,000 | +8.9% | 28,025 | +1.5% | 0.01% | +14.3% |
| Q2 2021 | $3,148,000 | -38.0% | 27,616 | -34.6% | 0.01% | -46.2% |
| Q1 2021 | $5,078,000 | +469.3% | 42,239 | +428.0% | 0.01% | +333.3% |
| Q2 2020 | $892,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |